|
|
Volumn 114, Issue 2, 2004, Pages 451-452
|
|
Neuropsychologic changes and inhaled corticosteroids [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE;
CORTICOSTEROID;
FLUTICASONE PROPIONATE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
PLACEBO;
THEOPHYLLINE;
ADRENAL CORTEX INSUFFICIENCY;
AGGRESSION;
ANGER;
ASTHMA;
ATTENTION DEFICIT DISORDER;
BEHAVIOR DISORDER;
CLINICAL FEATURE;
CLINICAL TRIAL;
DEPRESSION;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG MEGADOSE;
DRUG USE;
DRUG WITHDRAWAL;
ENURESIS;
EXCITABILITY;
FOLLOW UP;
HALLUCINATION;
HUMAN;
HYPERACTIVITY;
IRRITABILITY;
LETTER;
MAINTENANCE DRUG DOSE;
MENTAL DISEASE;
MOOD DISORDER;
NEUROPSYCHOLOGY;
PATHOGENESIS;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PSYCHOSIS;
RECURRENT DISEASE;
SIDE EFFECT;
SLEEP DISORDER;
SWEDEN;
SYSTEMIC DISEASE;
TREATMENT OUTCOME;
UPPER RESPIRATORY TRACT INFECTION;
VIRUS INFECTION;
ADMINISTRATION, INHALATION;
AGGRESSION;
BUDESONIDE;
CHILD, PRESCHOOL;
HUMANS;
INFANT;
PSYCHOMOTOR AGITATION;
|
|
EID: 4344667312
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaci.2004.03.045 Document Type: Letter |
|
Times cited : (20)
|
|
References (11)
|
